PDF herunterladen
CC BY-NC-ND 4.0 · World J Nucl Med 2020; 19(02): 147-148
DOI: 10.4103/wjnm.WJNM_68_19
Case Report

Occult tumour-induced osteomalacia causing lesion detected by FDG-PET/CT scan

Nitin Gupta
Department of Nuclear Medicine, Sir Gangaram Hospital, New Delhi
,
Natasha Singh
1   Department of Nuclear Medicine, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Oncogenic osteomalacia is a rare condition, with overproduction of fibroblast growth factor 23, leading to hypophosphatemia, phosphaturia. If it is associated with benign mesenchymal tumor, then resection of tumor is curable. Thus, detection and localization of the lesion are of utmost importance. We report a case, where 18F-FDG PET/CT scan was useful in detection of such occult lesion.

Keywords

FDG PET/CT scan - oncogenic osteomalacia - tumor-induced osteomalacia

Financial support and sponsorship

Nil.




Publikationsverlauf

Eingereicht: 25. August 2019

Angenommen: 17. September 2019

Artikel online veröffentlicht:
19. April 2022

© 2020. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Drezner MK. Tumor-induced osteomalacia. Rev Endocr Metab Disord 2001;2:175-86.
  • 2 Hesse E, Rosenthal H, Bastian L. Radiofrequency ablation of a tumor causing oncogenic osteomalacia. N Engl J Med 2007;357:422-4.
  • 3 Chokyu I, Ishibashi K, Goto T, Ohata K. Oncogenic osteomalacia associated with mesenchymal tumor in the middle cranial fossa: A case report. J Med Case Rep 2012;6:181.
  • 4 Reyes-Múgica M, Arnsmeier SL, Backeljauw PF, Persing J, Ellis B, Carpenter TO, et al. Phosphaturic mesenchymal tumor-induced rickets. Pediatr Dev Pathol 2000;3:61-9.
  • 5 Nguyen BD, Wang EA. Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia. Clin Nucl Med 1999;24:130-1.
  • 6 Clifton-Bligh RJ, Hofman MS, Duncan E, Sim IeW, Darnell D, Clarkson A. Improving diagnosis of tumor-induced osteomalacia with gallium-68 DOTATATE PET/CT. J Clin Endocrinol Metab 2013;98:687-94.
  • 7 Dupond JL, Mahammedi H, Prié D, Collin F, Gil H, Blagosklonov O, et al. Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case. Bone 2005;36:375-8.
  • 8 Seo HJ, Choi YJ, Kim HJ, Jeong YH, Cho A, Lee JH, et al. Using (18) F-FDG PET/CT to detect an occult mesenchymal tumor causing oncogenic osteomalacia. Nucl Med Mol Imaging 2011;45:233-7.